Results 11 to 20 of about 368,340 (301)

Important predictor of mortality in patients with end-stage liver disease [PDF]

Clinical and Molecular Hepatology, 2013
Prognosis is an essential part of the baseline assessment of any disease. For predicting prognosis of end-stage liver disease, many prognostic models were proposed.
Hyung Joon Kim, Hyun Woong Lee
doaj   +2 more sources

Cell therapy in end-stage liver disease: replace and remodel

Stem Cell Research & Therapy, 2023
Liver disease is prevalent worldwide. When it reaches the end stage, mortality rises to 50% or more. Although liver transplantation has emerged as the most efficient treatment for end-stage liver disease, its application has been limited by the scarcity ...
Xin-Hao Hu, Lan Chen, Hao Wu, Yang-Bo Tang, Qiu-Min Zheng, Xu-Yong Wei, Qiang Wei, Qi Huang, Jian Chen, Xiao Xu   +9 more
doaj   +2 more sources

Too little, too late: Palliation and end‐stage liver disease

, 2021
Background and Aim: End-stage liver disease is a leading cause of mortality. Fewer than 60% of patients with decompensated cirrhosis survive after 2 years, with patients often experiencing distressing symptoms impairing quality of life.
Paul Clark, Johnston, Alexander, Andrew Palmer, Timothy O'Sullivan, Matthew Mickenbecker, Palmer, Andrew, Alexander Johnston, Chen, Hayley, Hayley Chen, Mickenbecker, Matthew, O'Sullivan, Timothy, Clark, Paul   +11 more
core   +1 more source

Palliative Care in Advanced Liver Disease: Similar or Different Palliative Care Needs in Patients with a Prospect of Transplantation? Prospective Study from a Portuguese University Hospital and Transplantation Center

GE: Portuguese Journal of Gastroenterology, 2023
Background and Aims: End-stage liver disease (ESLD) is an important cause of morbidity and mortality, comparable to a large extent to other organ insufficiencies. The need for palliative care (PC) in patients with ESLD is high.
Sara Neves Vieira da Silva, Patricia Baptista, Isabel Fonseca Silva, Elga Freire, Helena Pessegueiro Miranda   +4 more
doaj   +1 more source

The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients

Frontiers in Medicine, 2022
Little is known about the shift of lymphocytes under the condition of the model for end-stage liver disease score and the follow-up period. Then, we detected the peripheral blood from liver transplant recipients by flow cytometry and compared the results.
Fei Pan, Shuang Cao, Xian-Liang Li, Ya-nan Jia, Ruo-lin Wang, Qiang He, Ji-Qiao Zhu   +6 more
doaj   +1 more source

Drug-related problems and dosage adjustment in patients with liver disease [PDF]

, 2012
The liver is essential for the metabolism of medicinal substances. Liver disease, especially liver cirrhosis, may lead to various pharmacokinetic and pharmacodynamic changes, predisposing patients with liver cirrhosis to adverse drug events (ADEs).
Franz, Carmen Carina
core   +1 more source

The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI) [PDF]

, 2012
BACKGROUND: Although liver function tests (LFTs) are routinely measured in primary care, raised levels in patients with no obvious liver disease may trigger a range of subsequent expensive and unnecessary management plans.
Roderick Paul, Donnan, Peter T, John F. Dillon (110507), Stephen D Ryder, McLernon, DJ, Rosenberg, WM, McLernon, D.J., McLernon David J., Roderick, P., William M. Rosenberg (110512), Roderick, Paul, Donnan, PT, Dillon, John F.; id_orcid, McLernon, David J., David J McLernon, Rosenberg, William M, Paul Roderick, Donnan, Peter T.; id_orcid, Sullivan, F.M., Dillon, J.F., Ryder, Stephen D., Sullivan, Frank M, Ryder, S.D., McLernon, David J, Rosenberg, William M., Dillon, John F., John F Dillon, Peter T. Donnan (110517), Donnan, Peter T., Roderick, P, Paul Roderick (14856), Donnan, P.T., Sullivan, FM, Ryder Stephen D., Sullivan Frank M., David J. McLernon (110505), Donnan Peter T., Peter T Donnan, Dillon, John F, Rosenberg, W.M., Frank M Sullivan, Rosenberg William M., Ryder, SD, Dillon, JF, Frank M. Sullivan (110508), William M Rosenberg, Sullivan, Frank M., Ryder, Stephen D, Dillon John F., Stephen D. Ryder (110515)   +49 more
core   +1 more source

Palliative Care in End-Stage Liver Disease Patients Awaiting Liver Transplantation: Review

GE: Portuguese Journal of Gastroenterology, 2020
Introduction: End-stage liver disease (ESLD) is the advanced phase of most liver diseases. The cure is liver transplantation (LT), only available for a minority of patients.
Sara Vieira Silva, Elga Freire, Helena Pessegueiro Miranda   +2 more
doaj   +1 more source

Palliative Care and End-Stage Liver Disease [PDF]

Clinical Gastroenterology and Hepatology, 2014
The concurrent care model of palliative care is a widely accepted model for how palliative care should be delivered (1). A palliative care approach is focused on improving the quality of life for a patient and often involves symptom management and communication about the disease process and overall goals of care.
Anne M, Walling, Neil S, Wenger
openaire   +2 more sources

Intrarenal Resistance Index as a Prognostic Parameter in Patients with Liver Cirrhosis Compared with Other Hepatic Scoring Systems [PDF]

, 2012
Background and Aims: Patients with advanced liver cirrhosis who develop renal dysfunction have a poor prognosis. Elevated intrarenal resistance indices (RIs) due to renal vascular constriction have been described before in cirrhotic patients.
Kaiser, C., M. Götzberger, C. Kaiser, J. Singer, V. Gülberg, Gülberg, Veit, Singer, J., Götzberger, M.   +7 more
core   +1 more source